UBS Group’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.7K | Sell |
8,385
-15,949
| -66% | -$123K | ﹤0.01% | 6295 |
|
|
2025
Q1 | $145K | Buy |
24,334
+23,500
| +2,818% | +$140K | ﹤0.01% | 5515 |
|
|
2024
Q4 | $11.1K | Buy |
834
+432
| +107% | +$5.75K | ﹤0.01% | 7023 |
|
|
2024
Q3 | $3.27K | Sell |
402
-1
| -0.2% | -$8 | ﹤0.01% | 7083 |
|
|
2024
Q2 | $3.43K | Sell |
403
-3,856
| -91% | -$32.8K | ﹤0.01% | 7052 |
|
|
2024
Q1 | $73.9K | Sell |
4,259
-143,470
| -97% | -$2.49M | ﹤0.01% | 5189 |
|
|
2023
Q4 | $1.89M | Buy |
147,729
+145,389
| +6,213% | +$1.86M | ﹤0.01% | 2896 |
|
|
2023
Q3 | $86.6K | Buy |
2,340
+285
| +14% | +$10.5K | ﹤0.01% | 4809 |
|
|
2023
Q2 | $82.7K | Sell |
2,055
-11,328
| -85% | -$456K | ﹤0.01% | 5105 |
|
|
2023
Q1 | $970K | Sell |
13,383
-828
| -6% | -$60K | ﹤0.01% | 3198 |
|
|
2022
Q4 | $1.17M | Buy |
14,211
+10,778
| +314% | +$884K | ﹤0.01% | 3018 |
|
|
2022
Q3 | $325K | Buy |
3,433
+1,800
| +110% | +$170K | ﹤0.01% | 3714 |
|
|
2022
Q2 | $318K | Sell |
1,633
-8,338
| -84% | -$1.62M | ﹤0.01% | 3644 |
|
|
2022
Q1 | $2.32M | Buy |
9,971
+147
| +1% | +$34.1K | ﹤0.01% | 2547 |
|
|
2021
Q4 | $3.87M | Buy |
9,824
+4,411
| +81% | +$1.74M | ﹤0.01% | 2330 |
|
|
2021
Q3 | $2.42M | Buy |
5,413
+4,141
| +326% | +$1.85M | ﹤0.01% | 2615 |
|
|
2021
Q2 | $494K | Sell |
1,272
-2,836
| -69% | -$1.1M | ﹤0.01% | 3759 |
|
|
2021
Q1 | $1.47M | Buy |
4,108
+3,976
| +3,012% | +$1.43M | ﹤0.01% | 3023 |
|
|
2020
Q4 | $65K | Sell |
132
-21
| -14% | -$10.3K | ﹤0.01% | 4968 |
|
|
2020
Q3 | $49K | Sell |
153
-46
| -23% | -$14.7K | ﹤0.01% | 4811 |
|
|
2020
Q2 | $72K | Sell |
199
-199
| -50% | -$72K | ﹤0.01% | 4737 |
|
|
2020
Q1 | $85K | Sell |
398
-1,110
| -74% | -$237K | ﹤0.01% | 4559 |
|
|
2019
Q4 | $621K | Sell |
1,508
-251
| -14% | -$103K | ﹤0.01% | 3721 |
|
|
2019
Q3 | $621K | Buy |
1,759
+1,619
| +1,156% | +$572K | ﹤0.01% | 3554 |
|
|
2019
Q2 | $70K | Buy |
140
+74
| +112% | +$37K | ﹤0.01% | 4788 |
|
|
2019
Q1 | $66K | Sell |
66
-27
| -29% | -$27K | ﹤0.01% | 4546 |
|
|
2018
Q4 | $80K | Sell |
93
-643
| -87% | -$553K | ﹤0.01% | 4841 |
|
|
2018
Q3 | $760K | Buy |
736
+703
| +2,130% | +$726K | ﹤0.01% | 3361 |
|
|
2018
Q2 | $30K | Sell |
33
-4,086
| -99% | -$3.71M | ﹤0.01% | 5462 |
|
|
2018
Q1 | $4.02M | Buy |
4,119
+4,068
| +7,976% | +$3.97M | ﹤0.01% | 2021 |
|
|
2017
Q4 | $23K | Buy |
51
+9
| +21% | +$4.06K | ﹤0.01% | 5475 |
|
|
2017
Q3 | $17K | Buy |
42
+41
| +4,100% | +$16.6K | ﹤0.01% | 5658 |
|
|
2017
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 6676 |
|
|
2017
Q1 | $0 | Sell |
1
-336
| -100% | – | ﹤0.01% | 6668 |
|
|
2016
Q4 | $120K | Buy |
337
+61
| +22% | +$21.7K | ﹤0.01% | 4283 |
|
|
2016
Q3 | $148K | Sell |
276
-25
| -8% | -$13.4K | ﹤0.01% | 3919 |
|
|
2016
Q2 | $169K | Buy |
301
+14
| +5% | +$7.86K | ﹤0.01% | 3848 |
|
|
2016
Q1 | $136K | Sell |
287
-1,115
| -80% | -$528K | ﹤0.01% | 4032 |
|
|
2015
Q4 | $925K | Buy |
1,402
+1,255
| +854% | +$828K | ﹤0.01% | 2738 |
|
|
2015
Q3 | $116K | Buy |
147
+28
| +24% | +$22.1K | ﹤0.01% | 4103 |
|
|
2015
Q2 | $158K | Buy |
119
+79
| +198% | +$105K | ﹤0.01% | 4022 |
|
|
2015
Q1 | $42K | Sell |
40
-4
| -9% | -$4.2K | ﹤0.01% | 4794 |
|
|
2014
Q4 | $29K | Buy |
+44
| New | +$29K | ﹤0.01% | 5178 |
|